Clinical Trial Update: A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age [Phase 3]

View source ↗

Summary

A Phase 3 study assessing the efficacy, safety, and immunogenicity of an adjuvanted influenza vaccine versus a non-adjuvanted influenza vaccine in adults aged 6…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Human

Drugs mentioned

• adjuvanted influenza vaccine (Seqirus investigation)

Snippet

Sponsor: Seqirus | Conditions: Influenza, Human | Phase 3 | Status: COMPLETED